Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema ; volume:12 ; number:1 ; day:17 ; month:10 ; year:2022 ; pages:1-7 ; date:12.2022
Scientific reports ; 12, Heft 1 (17.10.2022), 1-7, 12.2022
- Creator
-
Murakami, Tomoya
Okamoto, Fumiki
Sugiura, Yoshimi
Morikawa, Shohei
Okamoto, Yoshifumi
Hiraoka, Takahiro
Oshika, Tetsuro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-22401-y
- URN
-
urn:nbn:de:101:1-2023010220591934890259
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Murakami, Tomoya
- Okamoto, Fumiki
- Sugiura, Yoshimi
- Morikawa, Shohei
- Okamoto, Yoshifumi
- Hiraoka, Takahiro
- Oshika, Tetsuro
- SpringerLink (Online service)
Other Objects (12)
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
Correction: Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
The effects of intravitreal adalimumab injection on pseudophakic macular edema
Flare levels after intravitreal injection of brolucizumab for diabetic macular edema
Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
Full thickness macular hole case after intravitreal aflibercept treatment
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
Correction: Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
The effects of intravitreal adalimumab injection on pseudophakic macular edema
Flare levels after intravitreal injection of brolucizumab for diabetic macular edema
Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
Full thickness macular hole case after intravitreal aflibercept treatment
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection
Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
Correction: Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
The effects of intravitreal adalimumab injection on pseudophakic macular edema
Flare levels after intravitreal injection of brolucizumab for diabetic macular edema
Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
Full thickness macular hole case after intravitreal aflibercept treatment
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection